Injection Peptide Drug Market, Global Outlook and Forecast 2022-2028

April 2022 | 61 pages | ID: IF0F5DEF263FEN
Market Monitor Global

Abstracts

Peptides are short chains of amino acid monomers linked by peptide (amide) bonds, the covalent chemical bonds formed when the carboxyl group of one amino acid reacts with the amino group of another. Peptides are distinguished from proteins on the basis of size, and as a benchmark can be understood to contain approximately 50 amino acids or less.

This report contains market size and forecasts of Injection Peptide Drug in Global, including the following market information:

Global Injection Peptide Drug Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Injection Peptide Drug market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Intravenous Injection Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Injection Peptide Drug include Sanofi, Teva, Novo Nordisk, Takeda, Eli Lilly, AstraZeneca, Novartis, AbbVie and Ipsen, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Injection Peptide Drug companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Injection Peptide Drug Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Injection Peptide Drug Market Segment Percentages, by Type, 2021 (%)

• Intravenous Injection
• Subcutaneous Injection

Global Injection Peptide Drug Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Injection Peptide Drug Market Segment Percentages, by Application, 2021 (%)

• Cancer
• Metabolic Disorders
• Central Nervous System
• Other

Global Injection Peptide Drug Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Injection Peptide Drug Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Injection Peptide Drug revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Injection Peptide Drug revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Sanofi
• Teva
• Novo Nordisk
• Takeda
• Eli Lilly
• AstraZeneca
• Novartis
• AbbVie
• Ipsen
• Ferring
• Merck
• The Medicines
• J & J

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Injection Peptide Drug Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Injection Peptide Drug Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL INJECTION PEPTIDE DRUG OVERALL MARKET SIZE

2.1 Global Injection Peptide Drug Market Size: 2021 VS 2028
2.2 Global Injection Peptide Drug Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Injection Peptide Drug Players in Global Market
3.2 Top Global Injection Peptide Drug Companies Ranked by Revenue
3.3 Global Injection Peptide Drug Revenue by Companies
3.4 Top 3 and Top 5 Injection Peptide Drug Companies in Global Market, by Revenue in 2021
3.5 Global Companies Injection Peptide Drug Product Type
3.6 Tier 1, Tier 2 and Tier 3 Injection Peptide Drug Players in Global Market
  3.6.1 List of Global Tier 1 Injection Peptide Drug Companies
  3.6.2 List of Global Tier 2 and Tier 3 Injection Peptide Drug Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Injection Peptide Drug Market Size Markets, 2021 & 2028
  4.1.2 Intravenous Injection
  4.1.3 Subcutaneous Injection
4.2 By Type - Global Injection Peptide Drug Revenue & Forecasts
  4.2.1 By Type - Global Injection Peptide Drug Revenue, 2017-2022
  4.2.2 By Type - Global Injection Peptide Drug Revenue, 2023-2028
  4.2.3 By Type - Global Injection Peptide Drug Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Injection Peptide Drug Market Size, 2021 & 2028
  5.1.2 Cancer
  5.1.3 Metabolic Disorders
  5.1.4 Central Nervous System
  5.1.5 Other
5.2 By Application - Global Injection Peptide Drug Revenue & Forecasts
  5.2.1 By Application - Global Injection Peptide Drug Revenue, 2017-2022
  5.2.2 By Application - Global Injection Peptide Drug Revenue, 2023-2028
  5.2.3 By Application - Global Injection Peptide Drug Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Injection Peptide Drug Market Size, 2021 & 2028
6.2 By Region - Global Injection Peptide Drug Revenue & Forecasts
  6.2.1 By Region - Global Injection Peptide Drug Revenue, 2017-2022
  6.2.2 By Region - Global Injection Peptide Drug Revenue, 2023-2028
  6.2.3 By Region - Global Injection Peptide Drug Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Injection Peptide Drug Revenue, 2017-2028
  6.3.2 US Injection Peptide Drug Market Size, 2017-2028
  6.3.3 Canada Injection Peptide Drug Market Size, 2017-2028
  6.3.4 Mexico Injection Peptide Drug Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Injection Peptide Drug Revenue, 2017-2028
  6.4.2 Germany Injection Peptide Drug Market Size, 2017-2028
  6.4.3 France Injection Peptide Drug Market Size, 2017-2028
  6.4.4 U.K. Injection Peptide Drug Market Size, 2017-2028
  6.4.5 Italy Injection Peptide Drug Market Size, 2017-2028
  6.4.6 Russia Injection Peptide Drug Market Size, 2017-2028
  6.4.7 Nordic Countries Injection Peptide Drug Market Size, 2017-2028
  6.4.8 Benelux Injection Peptide Drug Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Injection Peptide Drug Revenue, 2017-2028
  6.5.2 China Injection Peptide Drug Market Size, 2017-2028
  6.5.3 Japan Injection Peptide Drug Market Size, 2017-2028
  6.5.4 South Korea Injection Peptide Drug Market Size, 2017-2028
  6.5.5 Southeast Asia Injection Peptide Drug Market Size, 2017-2028
  6.5.6 India Injection Peptide Drug Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Injection Peptide Drug Revenue, 2017-2028
  6.6.2 Brazil Injection Peptide Drug Market Size, 2017-2028
  6.6.3 Argentina Injection Peptide Drug Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Injection Peptide Drug Revenue, 2017-2028
  6.7.2 Turkey Injection Peptide Drug Market Size, 2017-2028
  6.7.3 Israel Injection Peptide Drug Market Size, 2017-2028
  6.7.4 Saudi Arabia Injection Peptide Drug Market Size, 2017-2028
  6.7.5 UAE Injection Peptide Drug Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Sanofi
  7.1.1 Sanofi Corporate Summary
  7.1.2 Sanofi Business Overview
  7.1.3 Sanofi Injection Peptide Drug Major Product Offerings
  7.1.4 Sanofi Injection Peptide Drug Revenue in Global Market (2017-2022)
  7.1.5 Sanofi Key News
7.2 Teva
  7.2.1 Teva Corporate Summary
  7.2.2 Teva Business Overview
  7.2.3 Teva Injection Peptide Drug Major Product Offerings
  7.2.4 Teva Injection Peptide Drug Revenue in Global Market (2017-2022)
  7.2.5 Teva Key News
7.3 Novo Nordisk
  7.3.1 Novo Nordisk Corporate Summary
  7.3.2 Novo Nordisk Business Overview
  7.3.3 Novo Nordisk Injection Peptide Drug Major Product Offerings
  7.3.4 Novo Nordisk Injection Peptide Drug Revenue in Global Market (2017-2022)
  7.3.5 Novo Nordisk Key News
7.4 Takeda
  7.4.1 Takeda Corporate Summary
  7.4.2 Takeda Business Overview
  7.4.3 Takeda Injection Peptide Drug Major Product Offerings
  7.4.4 Takeda Injection Peptide Drug Revenue in Global Market (2017-2022)
  7.4.5 Takeda Key News
7.5 Eli Lilly
  7.5.1 Eli Lilly Corporate Summary
  7.5.2 Eli Lilly Business Overview
  7.5.3 Eli Lilly Injection Peptide Drug Major Product Offerings
  7.5.4 Eli Lilly Injection Peptide Drug Revenue in Global Market (2017-2022)
  7.5.5 Eli Lilly Key News
7.6 AstraZeneca
  7.6.1 AstraZeneca Corporate Summary
  7.6.2 AstraZeneca Business Overview
  7.6.3 AstraZeneca Injection Peptide Drug Major Product Offerings
  7.6.4 AstraZeneca Injection Peptide Drug Revenue in Global Market (2017-2022)
  7.6.5 AstraZeneca Key News
7.7 Novartis
  7.7.1 Novartis Corporate Summary
  7.7.2 Novartis Business Overview
  7.7.3 Novartis Injection Peptide Drug Major Product Offerings
  7.7.4 Novartis Injection Peptide Drug Revenue in Global Market (2017-2022)
  7.7.5 Novartis Key News
7.8 AbbVie
  7.8.1 AbbVie Corporate Summary
  7.8.2 AbbVie Business Overview
  7.8.3 AbbVie Injection Peptide Drug Major Product Offerings
  7.8.4 AbbVie Injection Peptide Drug Revenue in Global Market (2017-2022)
  7.8.5 AbbVie Key News
7.9 Ipsen
  7.9.1 Ipsen Corporate Summary
  7.9.2 Ipsen Business Overview
  7.9.3 Ipsen Injection Peptide Drug Major Product Offerings
  7.9.4 Ipsen Injection Peptide Drug Revenue in Global Market (2017-2022)
  7.9.5 Ipsen Key News
7.10 Ferring
  7.10.1 Ferring Corporate Summary
  7.10.2 Ferring Business Overview
  7.10.3 Ferring Injection Peptide Drug Major Product Offerings
  7.10.4 Ferring Injection Peptide Drug Revenue in Global Market (2017-2022)
  7.10.5 Ferring Key News
7.11 Merck
  7.11.1 Merck Corporate Summary
  7.11.2 Merck Business Overview
  7.11.3 Merck Injection Peptide Drug Major Product Offerings
  7.11.4 Merck Injection Peptide Drug Revenue in Global Market (2017-2022)
  7.11.5 Merck Key News
7.12 The Medicines
  7.12.1 The Medicines Corporate Summary
  7.12.2 The Medicines Business Overview
  7.12.3 The Medicines Injection Peptide Drug Major Product Offerings
  7.12.4 The Medicines Injection Peptide Drug Revenue in Global Market (2017-2022)
  7.12.5 The Medicines Key News
7.13 J & J
  7.13.1 J & J Corporate Summary
  7.13.2 J & J Business Overview
  7.13.3 J & J Injection Peptide Drug Major Product Offerings
  7.13.4 J & J Injection Peptide Drug Revenue in Global Market (2017-2022)
  7.13.5 J & J Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Injection Peptide Drug Market Opportunities & Trends in Global Market
Table 2. Injection Peptide Drug Market Drivers in Global Market
Table 3. Injection Peptide Drug Market Restraints in Global Market
Table 4. Key Players of Injection Peptide Drug in Global Market
Table 5. Top Injection Peptide Drug Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Injection Peptide Drug Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Injection Peptide Drug Revenue Share by Companies, 2017-2022
Table 8. Global Companies Injection Peptide Drug Product Type
Table 9. List of Global Tier 1 Injection Peptide Drug Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Injection Peptide Drug Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Injection Peptide Drug Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Injection Peptide Drug Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Injection Peptide Drug Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Injection Peptide Drug Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Injection Peptide Drug Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Injection Peptide Drug Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Injection Peptide Drug Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Injection Peptide Drug Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Injection Peptide Drug Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Injection Peptide Drug Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Injection Peptide Drug Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Injection Peptide Drug Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Injection Peptide Drug Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Injection Peptide Drug Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Injection Peptide Drug Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Injection Peptide Drug Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Injection Peptide Drug Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Injection Peptide Drug Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Injection Peptide Drug Revenue, (US$, Mn), 2023-2028
Table 30. Sanofi Corporate Summary
Table 31. Sanofi Injection Peptide Drug Product Offerings
Table 32. Sanofi Injection Peptide Drug Revenue (US$, Mn), (2017-2022)
Table 33. Teva Corporate Summary
Table 34. Teva Injection Peptide Drug Product Offerings
Table 35. Teva Injection Peptide Drug Revenue (US$, Mn), (2017-2022)
Table 36. Novo Nordisk Corporate Summary
Table 37. Novo Nordisk Injection Peptide Drug Product Offerings
Table 38. Novo Nordisk Injection Peptide Drug Revenue (US$, Mn), (2017-2022)
Table 39. Takeda Corporate Summary
Table 40. Takeda Injection Peptide Drug Product Offerings
Table 41. Takeda Injection Peptide Drug Revenue (US$, Mn), (2017-2022)
Table 42. Eli Lilly Corporate Summary
Table 43. Eli Lilly Injection Peptide Drug Product Offerings
Table 44. Eli Lilly Injection Peptide Drug Revenue (US$, Mn), (2017-2022)
Table 45. AstraZeneca Corporate Summary
Table 46. AstraZeneca Injection Peptide Drug Product Offerings
Table 47. AstraZeneca Injection Peptide Drug Revenue (US$, Mn), (2017-2022)
Table 48. Novartis Corporate Summary
Table 49. Novartis Injection Peptide Drug Product Offerings
Table 50. Novartis Injection Peptide Drug Revenue (US$, Mn), (2017-2022)
Table 51. AbbVie Corporate Summary
Table 52. AbbVie Injection Peptide Drug Product Offerings
Table 53. AbbVie Injection Peptide Drug Revenue (US$, Mn), (2017-2022)
Table 54. Ipsen Corporate Summary
Table 55. Ipsen Injection Peptide Drug Product Offerings
Table 56. Ipsen Injection Peptide Drug Revenue (US$, Mn), (2017-2022)
Table 57. Ferring Corporate Summary
Table 58. Ferring Injection Peptide Drug Product Offerings
Table 59. Ferring Injection Peptide Drug Revenue (US$, Mn), (2017-2022)
Table 60. Merck Corporate Summary
Table 61. Merck Injection Peptide Drug Product Offerings
Table 62. Merck Injection Peptide Drug Revenue (US$, Mn), (2017-2022)
Table 63. The Medicines Corporate Summary
Table 64. The Medicines Injection Peptide Drug Product Offerings
Table 65. The Medicines Injection Peptide Drug Revenue (US$, Mn), (2017-2022)
Table 66. J & J Corporate Summary
Table 67. J & J Injection Peptide Drug Product Offerings
Table 68. J & J Injection Peptide Drug Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Injection Peptide Drug Segment by Type in 2021
Figure 2. Injection Peptide Drug Segment by Application in 2021
Figure 3. Global Injection Peptide Drug Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Injection Peptide Drug Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Injection Peptide Drug Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Injection Peptide Drug Revenue in 2021
Figure 8. By Type - Global Injection Peptide Drug Revenue Market Share, 2017-2028
Figure 9. By Application - Global Injection Peptide Drug Revenue Market Share, 2017-2028
Figure 10. By Region - Global Injection Peptide Drug Revenue Market Share, 2017-2028
Figure 11. By Country - North America Injection Peptide Drug Revenue Market Share, 2017-2028
Figure 12. US Injection Peptide Drug Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Injection Peptide Drug Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Injection Peptide Drug Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Injection Peptide Drug Revenue Market Share, 2017-2028
Figure 16. Germany Injection Peptide Drug Revenue, (US$, Mn), 2017-2028
Figure 17. France Injection Peptide Drug Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Injection Peptide Drug Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Injection Peptide Drug Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Injection Peptide Drug Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Injection Peptide Drug Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Injection Peptide Drug Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Injection Peptide Drug Revenue Market Share, 2017-2028
Figure 24. China Injection Peptide Drug Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Injection Peptide Drug Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Injection Peptide Drug Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Injection Peptide Drug Revenue, (US$, Mn), 2017-2028
Figure 28. India Injection Peptide Drug Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Injection Peptide Drug Revenue Market Share, 2017-2028
Figure 30. Brazil Injection Peptide Drug Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Injection Peptide Drug Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Injection Peptide Drug Revenue Market Share, 2017-2028
Figure 33. Turkey Injection Peptide Drug Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Injection Peptide Drug Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Injection Peptide Drug Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Injection Peptide Drug Revenue, (US$, Mn), 2017-2028
Figure 37. Sanofi Injection Peptide Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Teva Injection Peptide Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Novo Nordisk Injection Peptide Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Takeda Injection Peptide Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Eli Lilly Injection Peptide Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. AstraZeneca Injection Peptide Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Novartis Injection Peptide Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. AbbVie Injection Peptide Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Ipsen Injection Peptide Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Ferring Injection Peptide Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Merck Injection Peptide Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. The Medicines Injection Peptide Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 49. J & J Injection Peptide Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)